Per capita medicine use compound annual growth rate vs Sales growth at constant exchange rates

In 2026, per capita medicine use compound annual growth rate worldwide stood at 1.9% (forecast), against 17.8% for sales growth at constant exchange rates.

Change the pair

The series

Over time

Global, spaced by time. Both series are in %, so they share one axis; the legend names each line.

Per capita medicine use compound annual growth rate and Sales growth at constant exchange rates

Unit: % · 4 observations

2 series · one axis

Forecast: dashed line, hollow markers, shaded band

View the underlying data

Per capita medicine use compound annual growth rate and Sales growth at constant exchange rates: Global
Indicator	Period	Type	Value
Per capita medicine use compound annual growth rate	2026–2030	Forecast	1.9%
Per capita medicine use compound annual growth rate	2025–2030	Forecast	1.9%
Sales growth at constant exchange rates	Q2 2026	Actual	17.8%
Sales growth at constant exchange rates	Q1 2026	Actual	3%

Source: IQVIA, Roche, Sanofi · CC BY 4.0 · Per capita medicine use compound annual growth rate · Sales growth at constant exchange rates

Shared periods

Side by side

Only one period is published for both series. Comparing anything else would mean comparing different years.

Period	Per capita medicine use compound annual growth rate	Sales growth at constant exchange rates
2026	1.9%	17.8%

Provenance

Where these numbers come from